GB1477732A - Nutrient fluids - Google Patents

Nutrient fluids

Info

Publication number
GB1477732A
GB1477732A GB2634974A GB2634974A GB1477732A GB 1477732 A GB1477732 A GB 1477732A GB 2634974 A GB2634974 A GB 2634974A GB 2634974 A GB2634974 A GB 2634974A GB 1477732 A GB1477732 A GB 1477732A
Authority
GB
United Kingdom
Prior art keywords
nutrient fluid
maltose
hydrochloride
specified
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2634974A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU70037/74A priority Critical patent/AU7003774A/en
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to GB2634974A priority patent/GB1477732A/en
Priority to FR7420797A priority patent/FR2274279A1/fr
Priority to DE19742429034 priority patent/DE2429034A1/de
Publication of GB1477732A publication Critical patent/GB1477732A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB2634974A 1974-06-13 1974-06-13 Nutrient fluids Expired GB1477732A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU70037/74A AU7003774A (en) 1974-06-13 1974-06-12 Parenteral feeding method
GB2634974A GB1477732A (en) 1974-06-13 1974-06-13 Nutrient fluids
FR7420797A FR2274279A1 (fr) 1974-06-13 1974-06-14 Solution de maltose, notamment destinee a l'alimentation par voie parenterale
DE19742429034 DE2429034A1 (de) 1974-06-13 1974-06-18 Naehrfluessigkeit zur parenteralen verabfolgung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2634974A GB1477732A (en) 1974-06-13 1974-06-13 Nutrient fluids

Publications (1)

Publication Number Publication Date
GB1477732A true GB1477732A (en) 1977-06-22

Family

ID=10242291

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2634974A Expired GB1477732A (en) 1974-06-13 1974-06-13 Nutrient fluids

Country Status (4)

Country Link
AU (1) AU7003774A (xx)
DE (1) DE2429034A1 (xx)
FR (1) FR2274279A1 (xx)
GB (1) GB1477732A (xx)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2365344A1 (fr) * 1976-09-23 1978-04-21 Fresenius Chem Pharm Ind Solutions aqueuses d'une association d'hydrates de carbone, pour utilisation parenterale
JPS5793910A (en) * 1980-12-02 1982-06-11 Hayashibara Biochem Lab Inc Preparation of emulsion for intravenous injection
FR2561522A1 (fr) * 1984-03-20 1985-09-27 Egyt Gyogyszervegyeszeti Gyar Solution injectable, notamment pour le traitement de la cetose et son procede de preparation
CN115478037A (zh) * 2022-10-25 2022-12-16 湖南省农业环境生态研究所 一种用于培养贝莱斯芽孢杆菌yfb3-1的液体发酵培养基及方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
DE4316326C1 (de) * 1993-05-15 1994-06-09 Fresenius Ag Hochkalorische, niederosmolare Lösung zur totalen parenteralen Ernährung durch periphervenöse Applikation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2365344A1 (fr) * 1976-09-23 1978-04-21 Fresenius Chem Pharm Ind Solutions aqueuses d'une association d'hydrates de carbone, pour utilisation parenterale
JPS5793910A (en) * 1980-12-02 1982-06-11 Hayashibara Biochem Lab Inc Preparation of emulsion for intravenous injection
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
US4486417A (en) * 1980-12-02 1984-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Flurocarbon-water emulsion for hyperalimentation containing maltose
FR2561522A1 (fr) * 1984-03-20 1985-09-27 Egyt Gyogyszervegyeszeti Gyar Solution injectable, notamment pour le traitement de la cetose et son procede de preparation
GB2157561A (en) * 1984-03-20 1985-10-30 Egyt Gyogyszervegyeszeti Gyar An injectable solution especially for treating ketosis
CN115478037A (zh) * 2022-10-25 2022-12-16 湖南省农业环境生态研究所 一种用于培养贝莱斯芽孢杆菌yfb3-1的液体发酵培养基及方法

Also Published As

Publication number Publication date
DE2429034A1 (de) 1976-01-08
FR2274279A1 (fr) 1976-01-09
FR2274279B1 (xx) 1978-06-30
AU7003774A (en) 1975-12-18

Similar Documents

Publication Publication Date Title
CA2177195A1 (en) Method and composition for treating renal failure
CA1201385A (en) Elemental diets for liver diseases
Schneeman et al. Effect of dietary amino acids, casein, and soybean trypsin inhibitor on pancreatic protein secretion in rats
DK160351C (da) Diaettilskud med en specifik foroegende virkning paa menneskers stadium 4 soevn
Fürst New developments in glutamine delivery
GB1399888A (en) Injectable amino acid composition
DE60045524D1 (de) Ein Huhn GnRH-II Analog zur Verwendung in der Reduktion des Tumorzellwachstums
ATE84414T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
EP0182356B1 (en) Nutrient compositions
US5102871A (en) Nutrient composition
GB1477732A (en) Nutrient fluids
SE460096B (sv) Laekemedel foer behandling av diabetes, avsett foer oral administrering
CA2408501A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
Madden et al. Tolerance to amino acid mixtures and casein digests given intravenously: glutamic acid responsible for reactions
DE58906232D1 (de) Azelastin enthaltende Arzneimittel mit kontrollierter Wirkstoffabgabe.
CA1217725A (en) Amino acid-containing fat emulsion
AU2003211474A1 (en) Stabilized albumin preparaions
CA2134380C (en) Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
ATE541568T1 (de) Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten
BR0213823A (pt) Método de administração de um peptìdeo timosina alfa 1
Maekawa et al. Case of acute-onset type 1 diabetes induced by long-term immunotherapy with nivolumab in a patient with mucosal melanoma
DE68910126T2 (de) Nahrungsmittelzusammensetzung.
GB1460108A (en) Pharmaceutical preparations containing aspirin or indomethacin
JPS5543030A (en) Prophylactic and remedy for microbial infection disease

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee